POS0650 EVALUATION OF THE SURVIVAL AND SAFETY OF BIOLOGIC AND TARGETED SYNTHETIC DMARD IN PATIENTS WITH DIFFICULT-TO-TREAT RA USING DATA FROM THE BIOBADASER 3.0 REGISTRY | Publicación